zearalenone and Adrenocortical-Carcinoma

zearalenone has been researched along with Adrenocortical-Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for zearalenone and Adrenocortical-Carcinoma

ArticleYear
Relative quantification of the proteomic changes associated with the mycotoxin zearalenone in the H295R steroidogenesis model.
    Toxicon : official journal of the International Society on Toxinology, 2011, Volume: 58, Issue:6-7

    Zearalenone (ZEN) is a mycotoxin with endocrine disrupting effects having vast economic implications in e.g. pig farming. Structurally, ZEN resembles 17β-estradiol, and thus is able to bind to estrogen receptors (ER) in target cells. Because of this, it is also classified as a non-steroidal estrogen, a phytoestrogen, a mycoestrogen, and a growth promoter. Quantitative proteomic analysis was undertaken using stable-isotope labeling by amino acids in cell culture (SILAC) upon exposure of the steroidogenesis cell model H295R with ZEN to elucidate its effect on protein regulation. ZEN significantly regulated 21 proteins, including proteins with known endocrine disrupting effects and several oncogenes. In addition, network analysis using Ingenuity Pathway Analysis showed that ZEN affected the oxidative phosphorylation pathway and the mitochondrial dysfunction pathway, both previously reported to be involved in endocrine dysfunction.

    Topics: Adrenal Cortex Hormones; Adrenocortical Carcinoma; Estrogens, Non-Steroidal; Humans; Mitochondria; Oxidative Phosphorylation; Protein Interaction Maps; Proteomics; Tumor Cells, Cultured; Zearalenone

2011